We specialize in the formulation and drug delivery technologies for a range of injectables, including traditional liposomes, stealth (PEGylated) liposomes for drug delivery, sustained-release liposomes, and solubility-enhancing systems such as microemulsions and liposomes. Our services include formulation feasibility studies, process development and scale-up, formulation characterization, analytics, and non-clinical services. Our concentration ranges from a few milliliters to several liters.
Contact us to learn more about our liposome technology.
Customization of liposomes based on needs (standard liposomes, fluorescent liposomes, cationic liposomes, functionalized liposomes, targeted liposomes, lipid nanoparticles for DNA/mRNA/SiRNA delivery).
Passive loading of soluble and insoluble compounds.
Active loading of special compounds.
Development of all types of liposomes and other lipid-based drug delivery systems.
Specialization in formulating difficult compounds.
Formulation of small molecules, peptides/proteins, and nucleic acids.
Enhancement of solubility using liposomes and lipid-based systems.
Customization of liposomes based on needs (standard liposomes, fluorescent liposomes, cationic liposomes, functionalized liposomes, targeted liposomes, lipid nanoparticles for DNA/mRNA/SiRNA delivery).
Particle size (Brookhaven 90Plus, ZetaPALS).
Zeta potential and mobility (Brookhaven ZetaPALS, qNano).
Particle size distribution (qNano, Brookhaven ZetaPALS).
Drug encapsulation efficiency (various methods).
Microscopy (uniformity, drug crystals, centrifugation).
Particle shape, lamellarity, and substructure (cryo-TEM, FF-EM).
Phase transitions, lipid and liposome enthalpy, protein denaturation temperature (MicroCal VP-DSC).
Phase transitions, lipid and liposome enthalpy, protein denaturation temperature (MicroCal VP-DSC).
